Ira Winer

Effective expression of small interfering RNA in human cells

Cynthia P. Paul, Paul D. Good, Ira Winer et al. · Nature Biotechnology · 2002 · 825 citations

Effective Expression, Small Rna, Gene Expression +3

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

Panagiotis A. Konstantinopoulos, Su-Chun Cheng, Andrea E. Wahner Hendrickson et al. · The Lancet Oncology · 2020 · 227 citations · Full text

Medicine, Gemcitabine Versus Gemcitabine, Metronomic Therapy +6

ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation

Frank T. Kolligs, Marvin T. Nieman, Ira Winer et al. · Cancer Cell · 2002 · 157 citations · Full text

Tumor Biology, Transcriptional Regulation, Signaling Pathway +10

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006)

János L. Tanyi, Leslie M. Randall, Setsuko K. Chambers et al. · Journal of Clinical Oncology · 2022 · 141 citations · Full text

F3-Targeted Cisplatin-Hydrogel Nanoparticles as an Effective Therapeutic That Targets Both Murine and Human Ovarian Tumor Endothelial Cells <i>In vivo</i>

Ira Winer, Shouyan Wang, Youg-Eun Koo Lee et al. · Cancer Research · 2010 · 97 citations · Full text

Nanotherapeutics, Endothelial Cells, Engineering +18